Biolytix

Executive Summary

Biolytix AG is an ISO 17025-accredited independent laboratory in Schlieren, Switzerland, specializing in molecular biological and microbiological analysis services. Founded in 2016, the company serves environmental, food, and genetic testing sectors using core technologies such as real-time PCR and ELISA. As a private company, Biolytix participates in national and European innovation projects, positioning itself as a reliable partner for routine and research-based testing. Its service-based model and accreditation provide a steady revenue stream, though the company faces competition from larger, more diversified diagnostics firms. Given its niche focus and lack of recent funding rounds, Biolytix appears to be a stable but low-growth entity in the diagnostics ecosystem.

Upcoming Catalysts (preview)

• TBDExpansion of testing portfolio into new infectious disease markers70% success
• Q3 2026Participation in a European Horizon 2025/2026 research consortium60% success
• Q2 2026ISO 17025 re-accreditation with extended scope for food safety testing90% success